Core Laboratories Inc.: updates and filings

CLBNYSEEnergy · Oil & Gas Field Services, NEC

Price

$8.38

November 18, 2026Market cap $386M

What Ploutos Investor adds for Core Laboratories

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 5 fiscal years, from 2021
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 71 daysAround Jan 28, 2027 · for Q4 2026

last Oct 28, 2026next Jan 28, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Mar 23, 2026 latest annualOct 30, 2026 latest quarterly
  • Nov 16, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Nov 13, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 30, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Oct 28, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Aug 25, 2026Officer or director change
    Form8-K
  • Aug 14, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 14, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 6, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jul 30, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Jul 29, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Jun 29, 2026Employee stock plan reportfor the period to Dec 31, 2025
    Form11-K
  • May 15, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • May 15, 2026Conflict minerals report
    FormSD
  • May 13, 2026Shareholder vote
    Form8-K
  • May 1, 2026Quarterly reportfor the period to Mar 31, 2026
    Form10-Q
  • Apr 29, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Mar 31, 2026Annual report to shareholdersfor the period to Dec 31, 2025
    FormARS
  • Mar 31, 2026Additional annual meeting material
    FormDEFA14A
  • Mar 31, 2026Annual meeting proxy statement
    FormDEF 14A
  • Mar 26, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Mar 23, 2026Regulation FD disclosure
    Form8-K
  • Mar 23, 2026Annual reportfor the period to Dec 31, 2025
    Form10-K
  • Mar 17, 2026Results of operations (amendment)
    Form8-K/A
  • Mar 5, 2026Amended articles or bylaws
    Form8-K
  • Mar 3, 2026Notice that the annual report will be filed late
    FormNT 10-K

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jan 17, 2023.

The full analysis

What do Core Laboratories's filings show?

The filings are where every one of Core Laboratories's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.